NCT03802162View on ClinicalTrials.gov

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 15, 2019

Primary Completion Date

May 10, 2019

Study Completion Date

August 31, 2019

Conditions
Alzheimer's Disease (AD)
Interventions
DRUG

CKD-355A (D797/Memantine HCl 20mg)

once a day

DRUG

CKD-355B (D797/Memantine HCl 20mg)

once a day

DRUG

D797

once a day

DRUG

D324 (Memantine HCl 10mg)

twice a day

Trial Locations (1)

Unknown

Korea University Anam Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY